Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the maximum tolerated dose of Genexol®-PM plus
Carboplatin and evaluate the efficacy and safety of Genexol®-PM plus Carboplatin regimen in
subjects with advanced ovarian cancer.